Qiagen Submits EGFR Companion Dx to FDA
January 15, 2013
Qiagen Submits EGFR Companion Dx to FDA
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Eyeing 2014 FDA Submission for Unyvero System, Curetis Starts Clinical Trial
December 6, 2012 / GenomeWeb Daily News - FDA Clears Qiagen's Rotor-Gene Q MDx Platform, Influenza A/B Assay
April 17, 2012 / GenomeWeb Daily News - Genome Institute of Singapore, QuantuMDx Collaborate on Dx for Asia
May 21, 2013 / GenomeWeb Daily News - Roche Receives FDA Nod for New PGx Indication for Tarceva in Metastatic NSCLC with Companion Dx
May 15, 2013 / Pharmacogenomics Reporter - FDA Approves Roche Test as CDx for Tarceva for Treating Certain NSCLC Patients
May 15, 2013 / GenomeWeb Daily News